Beijing Scitop Bio Tech Co Ltd Working Capital to Net Assets Ratio
Beijing Scitop Bio Tech Co Ltd working capital to net assets ratio. Beijing Scitop Bio Tech Co Ltd (300858) has a Working Capital to Net Assets ratio of 37.0% as of June 2026. Working capital of CN¥662.84 Million (current assets of CN¥849.80 Million minus current liabilities of CN¥186.96 Million) is measured against net assets of CN¥1.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Working capital to net assets ratio of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart shows how Beijing Scitop Bio Tech Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 37.0%, reflecting working capital of CN¥662.84 Million against net assets of CN¥1.79 Billion CNY. See how many days can Beijing Scitop Bio Tech Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Beijing Scitop Bio Tech Co Ltd Working Capital to Net Assets Ratio by Year (2015–2025)
Beijing Scitop Bio Tech Co Ltd working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Beijing Scitop Bio Tech Co Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 46.1% | CN¥849.74 Million | CN¥1.84 Billion | CN¥977.34 Million | CN¥127.60 Million | ▼ -1.9 pp |
| 2024 | 48.0% | CN¥858.52 Million | CN¥1.79 Billion | CN¥954.71 Million | CN¥96.19 Million | ▼ -3.8 pp |
| 2023 | 51.8% | CN¥896.91 Million | CN¥1.73 Billion | CN¥955.55 Million | CN¥58.64 Million | ▼ -21.4 pp |
| 2022 | 73.2% | CN¥1.24 Billion | CN¥1.70 Billion | CN¥1.33 Billion | CN¥85.28 Million | ▲ +1.9 pp |
| 2021 | 71.3% | CN¥690.11 Million | CN¥967.40 Million | CN¥752.59 Million | CN¥62.47 Million | ▼ -4.0 pp |
| 2020 | 75.4% | CN¥702.77 Million | CN¥932.59 Million | CN¥767.21 Million | CN¥64.43 Million | ▲ +29.0 pp |
| 2019 | 46.3% | CN¥185.27 Million | CN¥399.83 Million | CN¥249.02 Million | CN¥63.75 Million | ▲ +2.8 pp |
| 2018 | 43.5% | CN¥131.29 Million | CN¥301.83 Million | CN¥200.47 Million | CN¥69.18 Million | ▼ -25.9 pp |
| 2017 | 69.4% | CN¥195.01 Million | CN¥281.09 Million | CN¥246.99 Million | CN¥51.99 Million | ▼ -3.7 pp |
| 2016 | 73.1% | CN¥142.15 Million | CN¥194.57 Million | CN¥209.84 Million | CN¥67.70 Million | ▼ -76.8 pp |
| 2015 | 149.8% | CN¥78.92 Million | CN¥52.67 Million | CN¥148.76 Million | CN¥69.83 Million | — |